Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 31.82 Billion SEK | 12.5% |
| 2022 | 28.29 Billion SEK | 4.59% |
| 2021 | 27.04 Billion SEK | -9.29% |
| 2020 | 29.81 Billion SEK | 12.27% |
| 2019 | 26.55 Billion SEK | 9.88% |
| 2018 | 24.17 Billion SEK | 7.45% |
| 2017 | 22.49 Billion SEK | -24.4% |
| 2016 | 29.75 Billion SEK | -1.58% |
| 2015 | 30.23 Billion SEK | 13.37% |
| 2014 | 26.66 Billion SEK | 5.47% |
| 2013 | 25.28 Billion SEK | 4.28% |
| 2012 | 24.24 Billion SEK | 10.95% |
| 2011 | 21.85 Billion SEK | -1.43% |
| 2010 | 22.17 Billion SEK | -2.82% |
| 2009 | 22.81 Billion SEK | 18.39% |
| 2008 | 19.27 Billion SEK | 17.19% |
| 2007 | 16.44 Billion SEK | 26.49% |
| 2006 | 13 Billion SEK | 9.43% |
| 2005 | 11.88 Billion SEK | 9.11% |
| 2004 | 10.88 Billion SEK | 18.87% |
| 2003 | 9.16 Billion SEK | 6.02% |
| 2002 | 8.64 Billion SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.3 Billion SEK | 10.54% |
| 2024 Q1 | 7.51 Billion SEK | -24.13% |
| 2024 Q3 | 7.87 Billion SEK | -5.24% |
| 2023 Q2 | 7.17 Billion SEK | 0.49% |
| 2023 Q1 | 7.14 Billion SEK | -15.97% |
| 2023 Q4 | 9.9 Billion SEK | 30.18% |
| 2023 Q3 | 7.6 Billion SEK | 6.01% |
| 2023 FY | 31.82 Billion SEK | 12.5% |
| 2022 Q1 | 6.18 Billion SEK | -22.61% |
| 2022 Q4 | 8.49 Billion SEK | 22.43% |
| 2022 FY | 28.29 Billion SEK | 4.59% |
| 2022 Q3 | 6.94 Billion SEK | 4.06% |
| 2022 Q2 | 6.67 Billion SEK | 7.89% |
| 2021 Q4 | 7.98 Billion SEK | 26.67% |
| 2021 FY | 27.04 Billion SEK | -9.29% |
| 2021 Q3 | 6.3 Billion SEK | -4.27% |
| 2021 Q2 | 6.58 Billion SEK | 6.78% |
| 2021 Q1 | 6.16 Billion SEK | -30.21% |
| 2020 Q4 | 8.83 Billion SEK | 10.82% |
| 2020 Q2 | 6.97 Billion SEK | 15.55% |
| 2020 Q1 | 6.03 Billion SEK | -29.01% |
| 2020 FY | 29.81 Billion SEK | 12.27% |
| 2020 Q3 | 7.97 Billion SEK | 14.42% |
| 2019 Q3 | 6.23 Billion SEK | -0.65% |
| 2019 Q4 | 8.49 Billion SEK | 36.27% |
| 2019 Q1 | 5.54 Billion SEK | -29.68% |
| 2019 Q2 | 6.27 Billion SEK | 13.14% |
| 2019 FY | 26.55 Billion SEK | 9.88% |
| 2018 Q3 | 5.68 Billion SEK | -0.84% |
| 2018 Q2 | 5.73 Billion SEK | 17.73% |
| 2018 Q1 | 4.86 Billion SEK | 157.02% |
| 2018 FY | 24.17 Billion SEK | 7.45% |
| 2018 Q4 | 7.89 Billion SEK | 38.84% |
| 2017 Q3 | 6.69 Billion SEK | -7.53% |
| 2017 FY | 22.49 Billion SEK | -24.4% |
| 2017 Q4 | 1.89 Billion SEK | -71.71% |
| 2017 Q1 | 6.66 Billion SEK | -30.02% |
| 2017 Q2 | 7.24 Billion SEK | 8.66% |
| 2016 Q3 | 6.92 Billion SEK | 0.03% |
| 2016 Q4 | 9.52 Billion SEK | 37.44% |
| 2016 FY | 29.75 Billion SEK | -1.58% |
| 2016 Q2 | 6.92 Billion SEK | 8.62% |
| 2016 Q1 | 6.37 Billion SEK | -32.28% |
| 2015 FY | 30.23 Billion SEK | 13.37% |
| 2015 Q4 | 9.41 Billion SEK | 35.99% |
| 2015 Q3 | 6.92 Billion SEK | -3.56% |
| 2015 Q2 | 7.18 Billion SEK | 6.99% |
| 2015 Q1 | 6.71 Billion SEK | -20.9% |
| 2014 FY | 26.66 Billion SEK | 5.47% |
| 2014 Q2 | 6.32 Billion SEK | 12.34% |
| 2014 Q1 | 5.63 Billion SEK | -27.39% |
| 2014 Q4 | 8.48 Billion SEK | 36.31% |
| 2014 Q3 | 6.22 Billion SEK | -1.61% |
| 2013 FY | 25.28 Billion SEK | 4.28% |
| 2013 Q4 | 7.75 Billion SEK | 32.6% |
| 2013 Q3 | 5.85 Billion SEK | -2.74% |
| 2013 Q2 | 6.01 Billion SEK | 6.2% |
| 2013 Q1 | 5.66 Billion SEK | -27.52% |
| 2012 Q4 | 7.81 Billion SEK | 40.2% |
| 2012 Q1 | 5.24 Billion SEK | -28.66% |
| 2012 Q2 | 5.61 Billion SEK | 6.98% |
| 2012 FY | 24.24 Billion SEK | 10.95% |
| 2012 Q3 | 5.57 Billion SEK | -0.68% |
| 2011 Q4 | 7.35 Billion SEK | 51.13% |
| 2011 FY | 21.85 Billion SEK | -1.43% |
| 2011 Q1 | 4.67 Billion SEK | -29.66% |
| 2011 Q2 | 4.96 Billion SEK | 6.25% |
| 2011 Q3 | 4.86 Billion SEK | -1.95% |
| 2010 Q3 | 5.01 Billion SEK | -11.15% |
| 2010 Q2 | 5.64 Billion SEK | 16.16% |
| 2010 Q1 | 4.86 Billion SEK | -28.96% |
| 2010 FY | 22.17 Billion SEK | -2.82% |
| 2010 Q4 | 6.64 Billion SEK | 32.32% |
| 2009 Q2 | 5.52 Billion SEK | 7.2% |
| 2009 FY | 22.81 Billion SEK | 18.39% |
| 2009 Q1 | 5.15 Billion SEK | 0.0% |
| 2009 Q4 | 6.84 Billion SEK | 29.3% |
| 2009 Q3 | 5.29 Billion SEK | -4.16% |
| 2008 FY | 19.27 Billion SEK | 17.19% |
| 2007 FY | 16.44 Billion SEK | 26.49% |
| 2006 FY | 13 Billion SEK | 9.43% |
| 2005 FY | 11.88 Billion SEK | 9.11% |
| 2004 FY | 10.88 Billion SEK | 18.87% |
| 2003 FY | 9.16 Billion SEK | 6.02% |
| 2002 FY | 8.64 Billion SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AVITA Medical, Inc. | 50.56 Million USD | -62847.719% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -3950.87% |
| QHSLab, Inc. | 1.4 Million USD | -2258744.07% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -3950.87% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 11.98 Million USD | -265534.32% |
| Aurora Spine Corporation | 14.52 Million USD | -219087.633% |
| BrainsWay Ltd. | 31.78 Million USD | -100032.138% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -4453047.299% |
| Hamilton Thorne Ltd. | 68.45 Million USD | -46391.068% |
| Vivos Inc. | 19.5 Thousand USD | -163215284.615% |
| Kelyniam Global, Inc. | 2.67 Million USD | -1190871.117% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -15622967.181% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -36747388.743% |
| Avitar, Inc. | 3.1 Million USD | -1024517.607% |
| Nanomix Corporation | 15.45 Thousand USD | -205999900.0% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | -60394.954% |
| Theraclion SA | 1.82 Million USD | -1746504.83% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 734.66 Thousand USD | -4332072.715% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -2359539.029% |
| Lombard Medical, Inc. | 12.16 Million USD | -261441.622% |
| ALR Technologies Inc. | 7468.00 USD | -426178261.007% |
| Stratec SE | 289.14 Million USD | -10907.135% |
| Vycor Medical, Inc. | 1.46 Million USD | -2178930.045% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 950.72 Million USD | -3247.656% |
| VMS Rehab Systems, Inc. | 71.70 USD | -44389121238.912% |
| NewCardio, Inc. | 257.39 Thousand USD | -12364749.902% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -32476430.612% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -4416158.024% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -37672121.959% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -4810874.227% |
| SANUWAVE Health, Inc. | 20.39 Million USD | -155930.003% |
| IR-Med Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -7886987.301% |
| Polarean Imaging plc | 890.93 Thousand USD | -3572222.498% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -1118495.673% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -1129564.164% |
| Urologix, Inc. | 14.23 Million USD | -223482.719% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -963544.208% |
| SS Innovations International, Inc. | 5.87 Million USD | -541202.207% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -79220808.525% |
| Smith & Nephew plc | 5.68 Billion USD | -460.069% |
| NIOX Group Plc | 46.84 Million USD | -67839.052% |
| Fuse Medical, Inc. | 16.11 Million USD | -197393.305% |
| Broncus Holding Corporation | 10.25 Million USD | -310255.924% |
| Brain Scientific Inc. | 214.56 Thousand USD | -14833236.44% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -1609142.361% |
| Health Logic Interactive Inc. | - USD | -Infinity% |